The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis
Open accessAbstract
With a 3‐fold increase in the number of cancer survivors noted since the 1970s, there are now over 28 million cancer survivors worldwide. Accordingly, there is a heightened awareness of long‐term toxicities and the impact on quality of life following treatment in cancer survivors. This review will address the increasing importance and challenge of chemotherapy‐induced neurotoxicity, with a focus on neuropathy associated with the treatment of breast cancer, colorectal cancer, testicular cancer, and hematological cancers. An overview of the diagnosis, symptomatology, and pathophysiology of chemotherapy‐induced peripheral neuropathy will be provided, with a critical analysis of assessment strategies, neuroprotective approaches, and potential treatments. The review will concentrate on neuropathy associated with taxanes, platinum compounds, vinca alkaloids, thalidomide, and bortezomib, providing clinical information specific to these chemotherapies. CA Cancer J Clin 2013;63:419‐437. © 2013 American Cancer Society, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2938 · Cited by 3,815
Self-citationOxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
André, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Zaninelli, M., Clingan, P., Bridgewater, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032709 · Cited by 3,689
Rolke, R., Baron, R., Maier, C., Tölle, T. R., Treede, D. R., Beyer, A., Binder, A., Birbaumer, N., Birklein, F., Bötefür, I. C., et al. (2006) · Pain · doi:10.1016/j.pain.2006.01.041 · Cited by 2,609
TROTTI, A., COLEVAS, A., SETSER, A., RUSCH, V, JAQUES, D., BUDACH, V, LANGER, C., MURPHY, B., CUMBERLIN, R., & COLEMAN, C. (2003) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(03)00031-6 · Cited by 2,569
Stewart, B. W., & Kleihues, P. (2003) · Cited by 2,386
André, T., Boni, C., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Bonetti, A., Clingan, P., Bridgewater, J., Rivera, F., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.6771 · Cited by 2,277
Yuki, N., & Hartung, H.-P. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1114525 · Cited by 1,260
Smith, E. M. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Bressler, L. R., Fadul, C. E., Knox, C., Le-Lindqwister, N., et al. (2013) · JAMA · doi:10.1001/jama.2013.2813 · Cited by 1,014
Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
Sparano, J. A., Wang, M., Martino, S., Jones, V., Perez, E. A., Saphner, T., Wolff, A. C., Sledge, G. W., Wood, W. C., & Davidson, N. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707056 · Cited by 997
Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma
Barlogie, B., Tricot, G., Anaissie, E., Shaughnessy, J., Rasmussen, E., van Rhee, F., Fassas, A., Zangari, M., Hollmig, K., Pineda-Roman, M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053583 · Cited by 739
Basch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M. G., Scher, H. I., & Schrag, D. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70910-x · Cited by 653
Richardson, P. G., Briemberg, H., Jagannath, S., Wen, P. Y., Barlogie, B., Berenson, J., Singhal, S., Siegel, D. S., Irwin, D., Schuster, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7779 · Cited by 649
Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
Wolf, S., Barton, D., Kottschade, L., Grothey, A., & Loprinzi, C. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.04.018 · Cited by 632
Seidman, A. D., Berry, D., Cirrincione, C., Harris, L., Muss, H., Marcom, P. K., Gipson, G., Burstein, H., Lake, D., Shapiro, C. L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.6699 · Cited by 594
Postma, T. J., Aaronson, N. K., Heimans, J. J., Muller, M. J., Hildebrand, J. G., Delattre, J. Y., Hoang-Xuan, K., Lantéri-Minet, M., Grant, R., Huddart, R., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.02.012 · Cited by 583
Ebell, M. H., Siwek, J., Weiss, B. D., Woolf, S. H., Susman, J., Ewigman, B., & Bowman, M. (2004) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.17.1.59 · Cited by 561
Fromme, E. K., Eilers, K. M., Mori, M., Hsieh, Y.-C., & Beer, T. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.025 · Cited by 555
Flatters, S. J. L., & Bennett, G. J. (2006) · Pain · doi:10.1016/j.pain.2006.01.037 · Cited by 535
Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force
Titulaer, M. J., Soffietti, R., Dalmau, J., Gilhus, N. E., Giometto, B., Graus, F., Grisold, W., Honnorat, J., Sillevis Smitt, P. A. E., Tanasescu, R., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03220.x · Cited by 526
Ebell, M. H., Siwek, J., Weiss, B. D., Woolf, S. H., Susman, J. L., Ewigman, B., & Bowman, M. A. (2004) · PubMed · Cited by 484
Basch, E., Abernethy, A. P., Mullins, C. D., Reeve, B. B., Smith, M. L., Coons, S. J., Sloan, J., Wenzel, K., Chauhan, C., Eppard, W., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.5967 · Cited by 476
Multiple measures of axonal excitability: A new approach in clinical testing
Kiernan, M. C., Burke, D., Andersen, K. V., & Bostock, H. (2000) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(200003)23:3<399::aid-mus12>3.0.co;2-g · Cited by 457
Self-citationTotal neuropathy score: Validation and reliability study
Cornblath, D. R., Chaudhry, V., Carter, K., Lee, D., Seysedadr, M., Miernicki, M., & Joh, T. (1999) · Neurology · doi:10.1212/wnl.53.8.1660 · Cited by 449
Cascinu, S., Catalano, V., Cordella, L., Labianca, R., Giordani, P., Baldelli, A. M., Beretta, G. D., Ubiali, E., & Catalano, G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.061 · Cited by 421
Green, M. C., Buzdar, A. U., Smith, T., Ibrahim, N. K., Valero, V., Rosales, M. F., Cristofanilli, M., Booser, D. J., Pusztai, L., Rivera, E., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.232 · Cited by 419
England, J. (1990) · Annual Review of Medicine · doi:10.1146/annurev.med.41.1.1 · Cited by 408
Diagnosis, Management, and Evaluation of Chemotherapy-Induced Peripheral Neuropathy
Hausheer, F. H., Schilsky, R. L., Bain, S., Berghorn, E. J., & Lieberman, F. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.12.010 · Cited by 408
Calhoun, E. A., Welshman, E. E., Chang, C.-H., Lurain, J. R., Fishman, D. A., Hunt, T. L., & Cella, D. (2003) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2003.13603.x · Cited by 392
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
Bringhen, S., Larocca, A., Rossi, D., Cavalli, M., Genuardi, M., Ria, R., Gentili, S., Patriarca, F., Nozzoli, C., Levi, A., et al. (2010) · Blood · doi:10.1182/blood-2010-07-294983 · Cited by 381
Nabholtz, J. M., Gelmon, K., Bontenbal, M., Spielmann, M., Catimel, G., Conte, P., Klaassen, U., Namer, M., Bonneterre, J., Fumoleau, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.6.1858 · Cited by 380
Paraneoplastic Neurologic Syndrome in the PNS Euronetwork Database: A European Study From 20 Centers
Giometto, B. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.341 · Cited by 373
Chaudhry, V., Rowinsky, E. K., Sartorius, S. E., Donehower, R. C., & Cornblath, D. R. (1994) · Annals of Neurology · doi:10.1002/ana.410350310 · Cited by 363
Rao, R. D., Michalak, J. C., Sloan, J. A., Loprinzi, C. L., Soori, G. S., Nikcevich, D. A., Warner, D. O., Novotny, P., Kutteh, L. A., Wong, G. Y., et al. (2007) · Cancer · doi:10.1002/cncr.23008 · Cited by 360
Mols, F., Beijers, T., Lemmens, V., van den Hurk, C. J., Vreugdenhil, G., & van de Poll-Franse, L. V. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.1514 · Cited by 359
Gregg, R. W., Molepo, J. M., Monpetit, V. J., Mikael, N. Z., Redmond, D., Gadia, M., & Stewart, D. J. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.5.795 · Cited by 358
Phase I study of oxaliplatin in patients with advanced cancer
Extra, J. M., Espie, M., Calvo, F., Ferme, C., Mignot, L., & Marty, M. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00684890 · Cited by 343
Gradishar, W. J., Krasnojon, D., Cheporov, S., Makhson, A. N., Manikhas, G. M., Clawson, A., & Bhar, P. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.5397 · Cited by 341
Albers, P., Siener, R., Krege, S., Schmelz, H.-U., Dieckmann, K.-P., Heidenreich, A., Kwasny, P., Pechoel, M., Lehmann, J., Kliesch, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0899 · Cited by 337
Ta, L. E., Espeset, L., Podratz, J., & Windebank, A. J. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.04.010 · Cited by 325
Richardson, P. G., Sonneveld, P., Schuster, M. W., Stadtmauer, E. A., Facon, T., Harousseau, J., Ben‐Yehuda, D., Lonial, S., Goldschmidt, H., Reece, D., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07573.x · Cited by 305
Interventions for preventing neuropathy caused by cisplatin and related compounds
Albers, J. W., Chaudhry, V., Cavaletti, G., & Donehower, R. C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005228.pub4 · Cited by 298
Cavaletti, G., Cornblath, D. R., Merkies, I. S. J., Postma, T. J., Rossi, E., Frigeni, B., Alberti, P., Bruna, J., Velasco, R., Argyriou, A. A., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds329 · Cited by 293
The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons
Adelsberger, H., Quasthoff, S., Grosskreutz, J., Lepier, A., Eckel, F., & Lersch, C. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00667-1 · Cited by 290
Nichols, C. R., Williams, S. D., Loehrer, P. J., Greco, F. A., Crawford, E. D., Weetlaufer, J., Miller, M. E., Bartolucci, A., Schacter, L., & Einhorn, L. H. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.7.1163 · Cited by 288
Cella, D., Peterman, A., Hudgens, S., Webster, K., & Socinski, M. A. (2003) · Cancer · doi:10.1002/cncr.11578 · Cited by 286
Cavaletti, G., Frigeni, B., Lanzani, F., Mattavelli, L., Susani, E., Alberti, P., Cortinovis, D., & Bidoli, P. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.008 · Cited by 274
Richardson, P. G., Xie, W., Mitsiades, C., Chanan-Khan, A. A., Lonial, S., Hassoun, H., Avigan, D. E., Oaklander, A. L., Kuter, D. J., Wen, P. Y., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.3087 · Cited by 274
Honnorat, J., Cartalat-Carel, S., Ricard, D., Camdessanche, J. P., Carpentier, A. F., Rogemond, V, Chapuis, F., Aguera, M., Decullier, E., Duchemin, A. M., et al. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.138016 · Cited by 272
Winer, E. P., Berry, D. A., Woolf, S., Duggan, D., Kornblith, A., Harris, L. N., Michaelson, R. A., Kirshner, J. A., Fleming, G. F., Perry, M. C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.048 · Cited by 270
Díaz-Rubio, E., Tabernero, J., Gómez-España, A., Massutí, B., Sastre, J., Chaves, M., Abad, A., Carrato, A., Queralt, B., Reina, J. J., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.8467 · Cited by 268
Ruzzo, A., Graziano, F., Loupakis, F., Rulli, E., Canestrari, E., Santini, D., Catalano, V., Ficarelli, R., Maltese, P., Bisonni, R., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.1844 · Cited by 266
Bortezomib-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat
Cavaletti, G., Gilardini, A., Canta, A., Rigamonti, L., Rodriguez-Menendez, V., Ceresa, C., Marmiroli, P., Bossi, M., Oggioni, N., D'Incalci, M., et al. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.11.010 · Cited by 265
Hershman, D. L., Weimer, L. H., Wang, A., Kranwinkel, G., Brafman, L., Fuentes, D., Awad, D., & Crew, K. D. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1278-0 · Cited by 264
Adams, R. A., Meade, A. M., Seymour, M. T., Wilson, R. H., Madi, A., Fisher, D., Kenny, S. L., Kay, E., Hodgkinson, E., Pope, M., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70102-4 · Cited by 264
NCCN Task Force Report: Management of Neuropathy in Cancer
Stubblefield, M. D., Burstein, H. J., Burton, A. W., Custodio, C. M., Deng, G. E., Ho, M., Junck, L., Morris, G. S., Paice, J. A., Tummala, S., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0078 · Cited by 257
Paraneoplastic peripheral neuropathy associated with anti‐Hu antibodies
Camdessanché, J., Antoine, J., Honnorat, J., Vial, C., Petiot, P., Convers, P., & Michel, D. (2002) · Brain · doi:10.1093/brain/awf006 · Cited by 254
Peripheral nerve damage associated with administration of taxanes in patients with cancer
Argyriou, A. A., Koltzenburg, M., Polychronopoulos, P., Papapetropoulos, S., & Kalofonos, H. P. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.01.008 · Cited by 240
Self-citationLand, S. R., Kopec, J. A., Cecchini, R. S., Ganz, P. A., Wieand, H. S., Colangelo, L. H., Murphy, K., Kuebler, J. P., Seay, T. E., Needles, B. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.6652 · Cited by 239
Marsh, S., Paul, J., King, C. R., Gifford, G., McLeod, H. L., & Brown, R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.4752 · Cited by 238
Strumberg, D., Brügge, S., Korn, M. W., Koeppen, S., Ranft, J., Scheiber, G., Reiners, C., Möckel, C., Seeber, S., & Scheulen, M. E. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf058 · Cited by 232
Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy
Park, S. B., Lin, C. S.-Y., Krishnan, A. V., Goldstein, D., Friedlander, M. L., & Kiernan, M. C. (2009) · Brain · doi:10.1093/brain/awp219 · Cited by 231
Self-citationTreatment-related peripheral neuropathy in multiple myeloma: the challenge continues
Delforge, M., Bladé, J., Dimopoulos, M. A., Facon, T., Kropff, M., Ludwig, H., Palumbo, A., Van Damme, P., San-Miguel, J. F., & Sonneveld, P. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70068-1 · Cited by 222
Argyriou, A. A., Cavaletti, G., Briani, C., Velasco, R., Bruna, J., Campagnolo, M., Alberti, P., Bergamo, F., Cortinovis, D., Cazzaniga, M., et al. (2013) · Cancer · doi:10.1002/cncr.27732 · Cited by 221
LaPointe, N. E., Morfini, G., Brady, S. T., Feinstein, S. C., Wilson, L., & Jordan, M. A. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.05.008 · Cited by 219
Broyl, A., Corthals, S. L., Jongen, J. L., van der Holt, B., Kuiper, R., de Knegt, Y., van Duin, M., el Jarari, L., Bertsch, U., Lokhorst, H. M., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70206-0 · Cited by 219
Durand, J. P., Deplanque, G., Montheil, V., Gornet, J. M., Scotte, F., Mir, O., Cessot, A., Coriat, R., Raymond, E., Mitry, E., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr045 · Cited by 217
McLeod, H. L., Sargent, D. J., Marsh, S., Green, E. M., King, C. R., Fuchs, C. S., Ramanathan, R. K., Williamson, S. K., Findlay, B. P., Thibodeau, S. N., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.7943 · Cited by 216
POEMS syndrome: Update on diagnosis, risk‐stratification, and management
Dispenzieri*, A. (2012) · American Journal of Hematology · doi:10.1002/ajh.23288 · Cited by 213
Lecomte, T., Landi, B., Beaune, P., Laurent-Puig, P., & Loriot, M.-A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2076 · Cited by 211
Mileshkin, L., Stark, R., Day, B., Seymour, J. F., Zeldis, J. B., & Prince, H. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.6689 · Cited by 211
Wang, W.-S., Lin, J.-K., Lin, T.-C., Chen, W.-S., Jiang, J.-K., Wang, H.-S., Chiou, T.-J., Liu, J.-H., Yen, C.-C., & Chen, P.-M. (2007) · The Oncologist · doi:10.1634/theoncologist.12-3-312 · Cited by 210
HUANG, H. Q., BRADY, M. F., CELLA, D., & FLEMING, G. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.00794.x · Cited by 209
Sittl, R., Lampert, A., Huth, T., Schuy, E. T., Link, A. S., Fleckenstein, J., Alzheimer, C., Grafe, P., & Carr, R. W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118058109 · Cited by 209
Rowinsky, E. K., Chaudhry, V., Cornblath, D. R., & Donehower, R. C. (1993) · PubMed · Cited by 208
Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy
Postma, T. J., Heimans, J. J., Muller, M. J., Ossenkoppele, G. J., Vermorken, J. B., & Aaronson, N. K. (1998) · Annals of Oncology · doi:10.1023/a:1008344507482 · Cited by 207
Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing
Forsyth, P. A., Balmaceda, C., Peterson, K., Seidman, A. D., Brasher, P., & Deangelis, L. M. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005805907311 · Cited by 199
Rothenberg, M. L., Cox, J. V., Butts, C., Navarro, M., Bang, Y.-J., Goel, R., Gollins, S., Siu, L. L., Laguerre, S., & Cunningham, D. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn370 · Cited by 198
Grothey, A., Nikcevich, D. A., Sloan, J. A., Kugler, J. W., Silberstein, P. T., Dentchev, T., Wender, D. B., Novotny, P. J., Chitaley, U., Alberts, S. R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.5911 · Cited by 198
Long-Term Neuropathy After Oxaliplatin Treatment: Challenging the Dictum of Reversibility
Park, S. B., Lin, C. S. Y., Krishnan, A. V., Goldstein, D., Friedlander, M. L., & Kiernan, M. C. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0248 · Cited by 198
Self-citationDose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening
Verstappen, C. C. P., Koeppen, S., Heimans, J. J., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000154642.45474.28 · Cited by 196
Attal, N., Bouhassira, D., Gautron, M., Vaillant, J. N., Mitry, E., Lepère, C., Rougier, P., & Guirimand, F. (2009) · Pain · doi:10.1016/j.pain.2009.03.024 · Cited by 195
Shimozuma, K., Ohashi, Y., Takeuchi, A., Aranishi, T., Morita, S., Kuroi, K., Ohsumi, S., Makino, H., Mukai, H., Katsumata, N., et al. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-009-0613-7 · Cited by 193
Rao, R. D., Flynn, P. J., Sloan, J. A., Wong, G. Y., Novotny, P., Johnson, D. B., Gross, H. M., Renno, S. I., Nashawaty, M., & Loprinzi, C. L. (2008) · Cancer · doi:10.1002/cncr.23482 · Cited by 193
Egbelakin, A., Ferguson, M. J., MacGill, E. A., Lehmann, A. S., Topletz, A. R., Quinney, S. K., Li, L., McCammack, K. C., Hall, S. D., & Renbarger, J. L. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.22845 · Cited by 192
Vitamin E neuroprotection for cisplatin neuropathy: A randomized, placebo-controlled trial
Pace, A., Giannarelli, D., Galiè, E., Savarese, A., Carpano, S., Della Giulia, M., Pozzi, A., Silvani, A., Gaviani, P., Scaioli, V., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d5279e · Cited by 191
Reeder, C. B., Reece, D. E., Kukreti, V., Chen, C., Trudel, S., Laumann, K., Hentz, J., Pirooz, N. A., Piza, J. G., Tiedemann, R., et al. (2010) · Blood · doi:10.1182/blood-2010-02-271676 · Cited by 190
Topp, K. S., Tanner, K. D., & Levine, J. D. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20000904)424:4<563::aid-cne1>3.0.co;2-u · Cited by 189
Paclitaxel drug delivery systems
Zhang, Z., Mei, L., & Feng, S.-S. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.752354 · Cited by 182
Peters, C. M., Jimenez-Andrade, J. M., Kuskowski, M. A., Ghilardi, J. R., & Mantyh, P. W. (2007) · Brain Research · doi:10.1016/j.brainres.2007.06.066 · Cited by 175
Acute Abnormalities of Sensory Nerve Function Associated With Oxaliplatin-Induced Neurotoxicity
Park, S. B., Goldstein, D., Lin, C. S.-Y., Krishnan, A. V., Friedlander, M. L., & Kiernan, M. C. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.3425 · Cited by 174
Self-citationKottschade, L. A., Sloan, J. A., Mazurczak, M. A., Johnson, D. B., Murphy, B. P., Rowland, K. M., Smith, D. A., Berg, A. R., Stella, P. J., & Loprinzi, C. L. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-010-1018-3 · Cited by 173
Gewandter, J. S., Fan, L., Magnuson, A., Mustian, K., Peppone, L., Heckler, C., Hopkins, J., Tejani, M., Morrow, G. R., & Mohile, S. G. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-1766-y · Cited by 172
Boige, V., Mendiboure, J., Pignon, J.-P., Loriot, M.-A., Castaing, M., Barrois, M., Malka, D., Trégouët, D.-A., Bouché, O., Le Corre, D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.2106 · Cited by 172
Cavaletti, G., Jann, S., Pace, A., Plasmati, R., Siciliano, G., Briani, C., Cocito, D., Padua, L., Ghiglione, E., Manicone, M., et al. (2006) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2006.00078.x · Cited by 170
Sprauten, M., Darrah, T. H., Peterson, D. R., Campbell, M. E., Hannigan, R. E., Cvancarova, M., Beard, C., Haugnes, H. S., Fosså, S. D., Oldenburg, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.4025 · Cited by 170
Adverse interactions between antifungal azoles and vincristine: review and analysis of cases
Moriyama, B., Henning, S. A., Leung, J., Falade‐Nwulia, O., Jarosinski, P., Penzak, S. R., & Walsh, T. J. (2012) · Mycoses · doi:10.1111/j.1439-0507.2011.02158.x · Cited by 164
Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia
Ramchandren, S., Leonard, M., Mody, R. J., Donohue, J. E., Moyer, J., Hutchinson, R., & Gurney, J. G. (2009) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2009.00230.x · Cited by 163
Brydoy, M., Oldenburg, J., Klepp, O., Bremnes, R. M., Wist, E. A., Wentzel-Larsen, T., Hauge, E. R., Dahl, O., & Fossa, S. D. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp413 · Cited by 162
Reeves, B. N., Dakhil, S. R., Sloan, J. A., Wolf, S. L., Burger, K. N., Kamal, A., Le‐Lindqwister, N. A., Soori, G. S., Jaslowski, A. J., Kelaghan, J., et al. (2012) · Cancer · doi:10.1002/cncr.27489 · Cited by 161
Tanabe, Y., Hashimoto, K., Shimizu, C., Hirakawa, A., Harano, K., Yunokawa, M., Yonemori, K., Katsumata, N., Tamura, K., Ando, M., et al. (2013) · International Journal of Clinical Oncology · doi:10.1007/s10147-011-0352-x · Cited by 160
Tabernero, J. M., Climent, M. A., Lluch, A. M., Albanell, J., Vermorken, J. B., Barnadas, A., Anton, A., Laurent, C., Mayordomo, J. I., Estaun, N., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh349 · Cited by 156
Long term effects of vincristine on the peripheral nervous system
Postma, T. J., Benard, B. A., Huijgens, P. C., Ossenkoppele, G. J., & Heimans, J. J. (1993) · Journal of Neuro-Oncology · doi:10.1007/bf01050259 · Cited by 154
Dzagnidze, A., Katsarava, Z., Makhalova, J., Liedert, B., Yoon, M., Kaube, H., Limmroth, V., & Thomale, J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0523-07.2007 · Cited by 152
Smith, R. E., Brown, A. M., Mamounas, E. P., Anderson, S., Lembersky, B. C., Atkins, J. H., Shibata, H. R., Báez, L., DeFusco, P. A., Davila, E., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3403 · Cited by 151
Dimopoulos, M. A., Mateos, M., Richardson, P. G. G., Schlag, R., Khuageva, N. K., Shpilberg, O., Kropff, M. H., Špıčka, I., Palumbo, A. P., Wu, K. L., et al. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01533.x · Cited by 147
Rodriguez, M. A., Pytlík, R., Kozák, T., Chhanabhai, M., Gascoyne, R. D., Lu, B., Deitcher, S. R., & Winter, J. N. (2009) · Cancer · doi:10.1002/cncr.24359 · Cited by 145
Argyriou, A. A., Chroni, E., Koutras, A. K., Iconomou, G., Papapetropoulos, S., Polychronopoulos, P., & Kalofonos, H. P. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0072-3 · Cited by 138
Perez, E. A., Suman, V. J., Rowland, K. M., et al. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.n.047 · Cited by 137
Webster, R. G., Brain, K. L., Wilson, R. H., Grem, J. L., & Vincent, A. C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706407 · Cited by 136
Thalidomide sensory neurotoxicity
Cavaletti, G., Beronio, A., Reni, L., Ghiglione, E., Schenone, A. E., Briani, C., Zara, G., Cocito, D., Isoardo, G., Ciaramitaro, P., et al. (2004) · Neurology · doi:10.1212/wnl.62.12.2291 · Cited by 135
Effect of CYP3A5 Expression on Vincristine Metabolism with Human Liver Microsomes
Dennison, J. B., Jones, D. R., Renbarger, J. L., & Hall, S. D. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.118471 · Cited by 134
Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity
Leskelä, S., Jara, C., Leandro-Garcia, L. J., Martínez, A., García-Donás, J., Hernando, S., Hurtado, A., Vicario, J. C. C., Montero‐Conde, C., Landa, I., et al. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.13 · Cited by 132
Wolf, S. L., Barton, D. L., Qin, R., Wos, E. J., Sloan, J. A., Liu, H., Aaronson, N. K., Satele, D., Mattar, B. I., Green, N. B., et al. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-011-1141-9 · Cited by 132
Cirillo, M., Venturini, M., Ciccarelli, L., Coati, F., Bortolami, O., & Verlato, G. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp287 · Cited by 125
Gay, F., Hayman, S. R., Lacy, M. Q., Buadi, F. K., Gertz, M. A., Kumar, S. K., Dispenzieri, A. A., Mikhael, J. R., Bergsagel, P. L., Dingli, D., et al. (2009) · Blood · doi:10.1182/blood-2009-08-239046 · Cited by 124
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics
Cavaletti, G., Alberti, P., & Marmiroli, P. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70131-0 · Cited by 123
Tofthagen, C., Visovsky, C. M., & Berry, D. L. (2012) · Oncology nursing forum · doi:10.1188/12.onf.e416-e424 · Cited by 119
Oldenburg, J., Fosså, S. D., & Dahl, A. A. (2006) · Quality of Life Research · doi:10.1007/s11136-005-5370-6 · Cited by 118
Sensory exam with a quantitative tuning fork
Pestronk, A., Florence, J. M., Levine, T., Al-Lozi, M., Lopate, G., Miller, T. M., Ramneantu, I., Waheed, W., & Stambuk, M. K. (2004) · Neurology · doi:10.1212/01.wnl.0000106939.41855.36 · Cited by 117
Cavaletti, G., Marzorati, L., Bogliun, G., Colombo, N., Marzola, M. M., Pittelli, M., & Tredici, G. (1992) · Cancer · Cited by 116
Pignata, S., Placido, S. D., Biamonte, R., et al. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-5 · Cited by 116
Mauri, D. N., Kamposioras, K. V., Tsali, L., Bristianou, M., Valachis, A., Karathanasi, I., Georgiou, C., & Polyzos, N. P. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.10.006 · Cited by 116
Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas
Haim, N., Epelbaum, R., Ben-Shahar, M., Yarnitsky, D., Simri, W., & Robinson, E. (1994) · Cancer · Cited by 115
Stubblefield, M. D., McNeely, M. L., Alfano, C. M., & Mayer, D. K. (2012) · Cancer · doi:10.1002/cncr.27463 · Cited by 112
Lin, P., Lee, M.-Y., Wang, W.-S., Yen, C., Chao, T., Hsiao, L., Yang, M., Chen, P., Lin, K., & Chiou, T.-J. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0018-9 · Cited by 112
Poruchynsky, M. S., Sackett, D. L., Robey, R. W., Ward, Y., Annunziata, C. M., & Fojo, T. (2008) · Cell Cycle · doi:10.4161/cc.7.7.5625 · Cited by 110
Basch, E., Bennett, A. V., & Pietanza, M. C. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr493 · Cited by 110
Theiß, C., & Meller, K. (2000) · Cell and Tissue Research · doi:10.1007/s004410050019 · Cited by 110
Cisplatin neuropathy: clinical course and neurophysiological findings
LoMonaco, M., Milone, M., Batocchi, A. P., Padua, L., Restuccia, D., & Tonali, P. A. (1992) · Journal of Neurology · doi:10.1007/bf00839140 · Cited by 109
Impact of oxaliplatin-induced neuropathy: a patient perspective
Bennett, B. K., Park, S. B., Lin, C. S.-Y., Friedlander, M. L., Kiernan, M. C., & Goldstein, D. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-012-1428-5 · Cited by 108
Self-citationLong-term platinum retention after treatment with cisplatin and oxaliplatin
Brouwers, E. E. M., Huitema, A. D. R., Beijnen, J. H., & Schellens, J. H. M. (2008) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-8-7 · Cited by 107
Theiß, C., & Meller, K. (1999) · Cell and Tissue Research · doi:10.1007/s004419900120 · Cited by 107
Longitudinal assessment of oxaliplatin-induced neuropathy
Burakgazi, A. Z., Messersmith, W. A., Vaidya, D. M., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31822cfc59 · Cited by 107
Johnson, D. C., Corthals, S. L., Walker, B. A., Ross, F. M., Gregory, W. M., Dickens, N. J., Lokhorst, H. M., Goldschmidt, H., Davies, F. E., Durie, B. G. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.0792 · Cited by 104
Griffith, K. A., Merkies, I. S. J., Hill, E., & Cornblath, D. R. (2010) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2010.00292.x · Cited by 102
Argyriou, A. A., Velasco, R., Briani, C., Cavaletti, G., Bruna, J., Alberti, P., Cacciavillani, M., Lonardi, S., Santos, C., Cortinovis, D. L., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds208 · Cited by 102
Shimozuma, K., Ohashi, Y., Takeuchi, A., Aranishi, T., Morita, S., Kuroi, K., Ohsumi, S., Makino, H., Katsumata, N., Kuranami, M., et al. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-012-1492-x · Cited by 101
Oldenburg, J., Kraggerud, S. M., Brydøy, M., Cvancarova, M., Lothe, R. A., & Fosså, S. D. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-70 · Cited by 100
Rivera, E., Mejia, J. A., Arun, B., Adinin, R. B., Walters, R. S., Brewster, A. M., Broglio, K. R., Yin, G., Esmaeli, B., Hortobágyi, G. N., et al. (2008) · Cancer · doi:10.1002/cncr.23321 · Cited by 99
Immune-mediated neuropathies in myeloma patients treated with bortezomib
Ravaglia, S., Corso, A., Piccolo, G., Lozza, A., Alfonsi, E., Mangiacavalli, S., Varettoni, M., Zappasodi, P., Moglia, A., Lazzarino, M., et al. (2008) · Clinical Neurophysiology · doi:10.1016/j.clinph.2008.08.007 · Cited by 98
Neurological toxicity of long‐term (>1 yr) thalidomide therapy in patients with multiple myeloma
Tosi, P., Zamagni, E., Cellini, C., Plasmati, R., Cangini, D., Tacchetti, P., Perrone, G., Pastorelli, F., Tura, S., Baccarani, M., et al. (2005) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00382.x · Cited by 98
Persistent Mobility Disability After Neurotoxic Chemotherapy
Hile, E. S., Fitzgerald, G. K., & Studenski, S. A. (2010) · Physical Therapy · doi:10.2522/ptj.20090405 · Cited by 97
Kidwell, K., Yothers, G., Ganz, P. A., Land, S. R., Ko, C. Y., Cecchini, R. S., Kopec, J. A., & Wolmark, N. (2012) · Cancer · doi:10.1002/cncr.27593 · Cited by 95
Persistent neuropathy after treatment with cisplatin and oxaliplatin
Brouwers, E. E. M., Huitema, A. D. R., Boogerd, W. J., Beijnen, J. H., & Schellens, J. H. M. (2009) · Acta Oncologica · doi:10.1080/02841860902806609 · Cited by 94
Kirchmair, R., Tietz, A. B., Panagiotou, E. M., Walter, D. H., Silver, M., Yoon, Y., Schratzberger, P., Weber, A. C., KUSANO, K. F., Weinberg, D. H., et al. (2006) · Molecular Therapy · doi:10.1038/sj.mt.6300019 · Cited by 92
Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis
von Schlippe, M., Fowler, C. J., & Harland, S. J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2006 · Cited by 92
Smith, E., Cohen, J. A., Pett, M. A., & Beck, S. L. (2010) · Cancer Nursing · doi:10.1097/ncc.0b013e3181c989a3 · Cited by 91
Follow-Up Psychophysical Studies in Bortezomib-Related Chemoneuropathy Patients
Boyette-Davis, J. A., Cata, J. P., Zhang, H., et al. (2011) · Journal of Pain · doi:10.1016/j.jpain.2011.04.008 · Cited by 90
Viala, K., Béhin, A., Maisonobe, T., Léger, J. M., Stojkovic, T., Davi, F., Leblond, V., & Bouché, P. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.125930 · Cited by 90
Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.
Kautio, A.-L., Haanpää, M. L., Leminen, A., Kalso, E. A., Kautiainen, H., & Saarto, T. (2009) · PubMed · Cited by 89
Fountzilas, G., Dafni, U. G., Dimopoulos, M. A., Koutras, A. K., Skarlos, D. V., Papakostas, P., Gogas, H. J., Bafaloukos, D. I., Kalogera‐Fountzila, A., Samantas, E., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0047-9 · Cited by 87
Erythropoietin protects sensory axons against paclitaxel-induced distal degeneration
Melli, G., Jack, C., Lambrinos, G. L., Ringkamp, M., & Höke, A. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.014 · Cited by 84
Krarup‐Hansen, Rietz, Krarup, Heydorn, Rørth, & Schmalbruch (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00160.x · Cited by 82
Won, H., Lee, J., Park, J. O., Park, Y. S., Lim, H. Y., Kang, W. K., Kim, J., Lee, S., & Park, S. H. (2011) · Cancer · doi:10.1002/cncr.26614 · Cited by 80
Self-citationAn Update on Monoclonal Gammopathy and Neuropathy
Ramchandren, S., & Lewis, R. A. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0237-4 · Cited by 80
Frigeni, B., Piatti, M., Lanzani, F., Alberti, P., Villa, P., Zanna, C., Ceracchi, M., Ildebrando, M., & Cavaletti, G. (2011) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2011.00351.x · Cited by 80
Moore, D. H., Donnelly, J. P., McGuire, W. P., Almadrones, L., Cella, D. F., Herzog, T. J., & Waggoner, S. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.086 · Cited by 80
Bergmann, T. K., Gréen, H., Brasch‐Andersen, C., Mirza, M. R., Herrstedt, J., Hølund, B., du Bois, A., Damkier, P., Vach, W., Brøsen, K., et al. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1007-6 · Cited by 79
Casafont, Í., Berciano, M. T., & Lafarga, M. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9086-1 · Cited by 78
Grimison, P., Stockler, M. R., Thomson, D. B., Olver, I., Harvey, V. J., Gebski, V., Lewis, C. R., Levi, J. A., Boyer, M. J., Gurney, H., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq245 · Cited by 76
Permeation of proteins from the blood into peripheral nerves and ganglia
Allen, D. T., & Kiernan, J. A. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90192-9 · Cited by 75
Evidence for direct axonal toxicity in vincristine neuropathy
Silva-Figueroa, A. M., Wang, Q., Wang, M.-S., Ravula, S. K., & Glass, J. D. (2006) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2006.0090.x · Cited by 66
Thalidomide neuropathy: clinical, electrophysiological and neuroradiological features
Isoardo, G., Bergui, M., Durelli, L., et al. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00203.x · Cited by 64
Taxane-induced peripheral neuropathy has good long-term prognosis: a 1- to 13-year evaluation
Osmani, K., Vignes, S., Aissi, M., Wade, F. M., Milani, P., Levy, B. I., & Kubis, N. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6442-5 · Cited by 59
Kropff, M. H., Baylon, H. G., Hillengaß, J., Robak, T., Hájek, R., Liebisch, P., Goranova-Marinova, V. S., Hulin, C., Bladé, J., Caravita, T., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.044271 · Cited by 56
Moser, E. C., Noordijk, E. M., Carde, P. P., Tirelli, U., Baars, J. W., Thomas, J., Bron, D., Meerwaldt, J. H., Glabbeke, M. M. V., Raemaekers, J. M. M., et al. (2005) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2005.n.038 · Cited by 56
Naumann, R., Mohm, J., Reuner, U., Kroschinsky, F., Rautenstrauss, B. W., & Ehninger, G. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03126.x · Cited by 55
Binda, D., Vanhoutte, E. K., Cavaletti, G., Cornblath, D. R., Postma, T. J., Frigeni, B., Alberti, P., Bruna, J., Velasco, R., Argyriou, A. A., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.04.004 · Cited by 55
Interventions for preventing neuropathy caused by cisplatin and related compounds
Albers, J. W., Chaudhry, V., Cavaletti, G., & Donehower, R. C. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005228.pub2 · Cited by 54
Chemotherapy-related polyneuropathy may deteriorate quality of life in patients with B-cell lymphoma
Kim, B., Park, H.-R., Roh, H., Jeong, D., Kim, B. S., Park, K. W., Cho, S. C., So, Y. T., Oh, S. Y., & Kim, S. J. (2010) · Quality of Life Research · doi:10.1007/s11136-010-9670-0 · Cited by 52
Richardson, P. G. G., Laubach, J. P., Schlossman, R. L., Mitsiades, C. S., & Anderson, K. C. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0115 · Cited by 47
Madi, A., Fisher, D. J., Wilson, R. H., Adams, R., Meade, A. M., Kenny, S., Nichols, L., Seymour, M., Wasan, H. S., Kaplan, R. S., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.384 · Cited by 46
Feyler, S., Rawstron, A. C., Jackson, G. H., Snowden, J. A., Cocks, K., & Johnson, R. J. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06817.x · Cited by 45
Peripheral Neurotoxicity of Weekly Paclitaxel Chemotherapy: A Schedule or a Dose Issue?
Pace, A., Nisticò, C., Cuppone, F., et al. (2007) · Clinical Breast Cancer · doi:10.3816/cbc.2007.n.010 · Cited by 45
Wen, F., Zhou, Y., Wang, W., Hu, Q., Liu, Y. T., Zhang, P. F., Du, Z., Dai, J., & Li, Q. (2012) · Annals of Oncology · doi:10.1093/annonc/mds211 · Cited by 42
Cella, D. F., Huang, H. Q., Homesley, H. D., MONTAG, A. G., Salani, R., Geest, K. D., Lee, R., & Spirtos, N. M. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.08.022 · Cited by 38
Bortezomib-induced severe autonomic neuropathy
Stratogianni, A., Tosch, M., Schlemmer, H., Weis, J., Katona, I., Isenmann, S., & Haensch, C. (2012) · Clinical Autonomic Research · doi:10.1007/s10286-012-0164-8 · Cited by 35
Cheikh, J. E., Stoppa, A., Bouabdallah, R., de Lavallade, H., Coso, D., de Collela, J. M. S., Auran-Schleinitz, T., Gastaut, J., Blaise, D., & Mohty, M. (2008) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2008.n.017 · Cited by 35
Baloch, R., & Jakhrani, N. K. (1997) · CRC Press eBooks · doi:10.1201/9781420001143-62 · Cited by 35
Schröder, C. P., de Munck, L., Westermann, A. M., Smit, W. M., Creemers, G., de Graaf, H., Stouthard, J. M., van Deijk, G., Erjavec, Z., van Bochove, A., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.12.018 · Cited by 33
Inoue, N., Ishida, H., Sano, M., Kishino, T., Okada, N., Kumamoto, K., & Ishibashi, K. (2011) · International Journal of Clinical Oncology · doi:10.1007/s10147-011-0298-z · Cited by 29
Grothey, A. F. (2010) · Oncology · doi:10.1159/000323491 · Cited by 29
Yakoub‐Agha, I., Mary, J., Hulin, C., Doyen, C., Marit, G., Benboubker, L., Voillat, L., Moreau, P., Berthou, C., Stoppa, A., et al. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01729.x · Cited by 23
Patient-Reported Outcomes in Chemotherapy-Induced Peripheral Neuropathy: A Review
Sasané, M., Tencer, T., French, A., Maro, T., & Beusterien, K. M. (2010) · The Journal of Supportive Oncology · doi:10.1016/j.suponc.2010.09.029 · Cited by 23
Paraneoplastic disorders of the peripheral nervous system
Antoine, J.-C. G., & Camdessanché, J. (2013) · La Presse Médicale · doi:10.1016/j.lpm.2013.01.059 · Cited by 17
Grothey, A. F., Qin, R., Dakhil, S. R., Fehrenbacher, L., Stella, P. J., Atherton, P. J., Seisler, D. K., Qamar, R., Lewis, G., & Loprinzi, C. L. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt201.32 · Cited by 14
Cited by
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Seretny, M., Currie, G. L., Sena, E. S., Ramnarine, S., Grant, R., MacLeod, M. R., Colvin, L. A., & Fallon, M. (2014) · Pain · doi:10.1016/j.pain.2014.09.020 · Cited by 1,555
Microbiota: a key orchestrator of cancer therapy
Roy, S., & Trinchieri, G. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.13 · Cited by 883
Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
Zajączkowska, R., Kocot-Kępska, M., Leppert, W., Wrzosek, A., Mika, J., & Wordliczek, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061451 · Cited by 829
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
Starobova, H., & Vetter, I. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00174 · Cited by 648
Metadata
- Authors
- Park, S. B., Goldstein, D., Krishnan, A. V., Lin, C. S., Friedlander, M. L., Cassidy, J., Koltzenburg, M., & Kiernan, M. C.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2013-11
- Volume
- 63
- Issue
- 6
- Pages
- 419-437
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W2143341124
- Cited by
- 741
- References
- 186
- FWCI
- 12.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.